- 1) Gaffney, P. J., Edgell, T. A., Dawson, P. A., Ford, A. W., and Stocker, E., A pig collagen peptide fraction. A unique material for maintaining biological activity during lyophilization and during storage in the liquid state. J. Pharm. Pharmacol., 48, 896–898 (1996).
- 2) Khare, S. D., Krco, C. J., Griffiths, M. M., Luthra, H. S., and David, C. S., Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J. Immunol., 155, 3653–3659 (1995).
- 3) Ku, G., Kronenberg, M., Peacock, D. J., Tempst, P., Banquerigo, M. L., Braun, B. S., Reeve Jr., J. R., and Brahn, E., Prevention of experimental autoimmune arthritis with a peptide fragment of type II collagen. Eur. J. Immunol., 23, 591–599 (1993).
- 4) Sakai, Y., Yamato, R., Onuma, M., Kikuta, T., Watanabe, M., and Nakayama, T., Non-antigenic and low allergic gelatin produced by specific digestion with an enzyme-coupled matrix. Biol. Pharm. Bull., 21, 330–334 (1998).
- 5) Tsuruoka, N., Nakayama, T., Ashida, M., Hemmi, H., Nakao, M., Minakata, H., Oyama, H., Oda, K., and Nishino, T., Collagenolytic serine-carboxyl proteinase from Alicyclobacillus sendaiensis strain NTAP-1: purification, characterization, gene cloning, and heterologous expression. Appl. Environ. Microbiol., 69, 162–169 (2003).
- 6) Yamato, R., Effect of HACP on the process of fracture healing in rat. Food Processing (in Japanese, anecdotal report), 39, 54–55 (2001).
- 7) Li, C., Mori, S., Li, J., Kaji, Y., Akiyama, T., Kawanishi, J., and Norimatsu, H., Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J. Bone Miner. Res., 16, 429–436 (2001).
- 8) Harris, S. A., Enger, R. J., Riggs, B. L., and Spelsberg, T. C., Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J. Bone Miner. Res., 10, 178–186 (1995).
- 9) Reinholz, G. G., Getz, B., Pederson, L., Sanders, E. S., Subramaniam, M., Ingle, J. N., and Spelsberg, T. C., Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res., 60, 6001–6007 (2000).
- 10) Melkko, J., Niemi, S., Risteli, L., and Risteli, J., Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin. Chem., 36, 1328–1332 (1990).
- 11) Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248–254 (1976).
- 12) Li, J., Mori, S., Kaji, Y., Mashiba, T., Kawanishi, J., and Norimatsu, H., Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats. J. Bone Miner. Res., 14, 969–979 (1999).
- 13) Stein, G. S., and Lian, J. B., Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev., 14, 424–442 (1993).
- 14) Ogata, K., Imazato, S., Ehara, A., Ebisu, S., Kinomoto, Y., Nakano, T., and Umakoshi, Y., Comparison of osteoblast responses to hydroxyapatite and hydroxyapatite/soluble calcium phosphate composites. J. Biomed. Mater. Res. A, 72, 127–135 (2005).
- 15) Kim, H. W., Kim, H. E., and Salih, V., Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin-hydroxyapatite for tissue engineering scaffolds. Biomaterials, 26, 5221–5230 (2005).
- 16) Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., and de Crombrugghe, B., The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell, 108, 17–29 (2002).
- 17) Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S., and Kishimoto, T., Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89, 755–764 (1997).
- 18) Takahashi, T., Kato, S., Suzuki, N., Kawabata, N., and Takagi, M., Autoregulatory mechanism of Runx2 through the expression of transcription factors and bone matrix proteins in multipotential mesenchymal cell line, ROB-C26. J. Oral Sci., 47, 199–207 (2005).
- 19) Lee, K. S., Kim, H. J., Li, Q. L., Chi, X. Z., Ueta, C., Komori, T., Wozney, J. M., Kim, E. G., Choi, J. Y., Ryoo, H. M., and Bae, S. C., Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol., 20, 8783–8792 (2000).
- 20) Phimphilai, M., Zhao, Z., Boules, H., Roca, H., and Franceschi, R. T., BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J. Bone Miner. Res., 21, 637–646 (2006).
- 21) Yagi, K., Tsuji, K., Nifuji, A., Shinomiya, K., Nakashima, K., DeCrombrugghe, B., and Noda, M., Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes. J. Cell. Biochem., 88, 1077–1083 (2003).
- 22) Chou, M. M., and Blenis, J., The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling. Curr. Opin. Cell Biol., 7, 806–814 (1995).
- 23) Adibi, S. A., Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am. J. Physiol. Gastrointest. Liver Physiol., 285, G779–788 (2003).
- 24) Iwai, K., Hasegawa, T., Taguchi, Y., Morimatsu, F., Sato, K., Nakamura, Y., Higashi, A., Kido, Y., Nakabo, Y., and Ohtsuki, K., Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J. Agric. Food Chem., 53, 6531–6536 (2005).
- 25) Ohara, H., Matsumoto, H., Ito, K., Iwai, K., and Sato, K., Comparison of quantity and structures of hydroxyproline-containing peptides in human blood after oral ingestion of gelatin hydrolysates from different sources. J. Agric. Food Chem., 55, 1532–1535 (2007).
Bioscience, Biotechnology, and Biochemistry
Volume 71, 2007 - Issue 11